Insights
Search Results
Client Highlights
6.02.26
Wilson Sonsini Advises Contentful on Acquisition by Salesforce
On June 1, 2026, Salesforce, the world's No. 1 AI CRM, announced that it has signed a definitive agreement to acquire Contentful, a leading composable content platform trusted by over 4,800 of the world’s leading brands to deliver personalized digital experiences at scale. Wilson Sonsini Goodrich & Rosati advised Contentful on the transaction.
Client Highlights
5.26.26
Firm Advises Greenhouse on Acquisition of Ezra AI Labs
On May 5, 2026, Greenhouse, a leading hiring platform, announced it has entered into a definitive agreement to acquire Ezra AI Labs, a voice AI interviewer that delivers structured, on-demand conversations that feel natural rather than robotic. Once closed, the acquisition will deepen Greenhouse's ability to help companies identify genuine talent in a job market overwhelmed by AI-generated applications. Wilson Sonsini Goodrich & Rosati advised Greenhouse on the transaction.
Client Highlights
3.30.26
Wilson Sonsini Advises Octopus Energy on Majority Stake Acquisition of Uplight
On March 24, 2026, Octopus Energy Group, a global clean energy and technology business driving the affordable, green energy system of the future, will cement its expansion in the U.S. by acquiring a majority stake in Uplight, a leading provider of customer engagement and flexibility management solutions that rapidly transform customer participation into dependable grid capacity. The deal is made in partnership with Schneider Electric, a global energy technology leader trusted by utilities worldwide, which will remain as a significant minority partner. The transaction is subject to customary regulatory approvals and is expected to complete later this year. Wilson Sonsini Goodrich & Rosati advised Octopus Energy on the transaction.
Client Highlights
3.13.26
Wilson Sonsini Advises Urgently on Acquisition by Agero
On March 13, 2026, Agero, a software-enabled driver safety services and technology company, announced that it has entered into an agreement to acquire Urgent.ly (Urgently), a digital software platform that provides roadside and mobility assistance, for a cash price of $5.50 per share. The tender offer and merger are expected to close by the end of May 2026, subject to satisfaction of customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Urgently on the transaction.
Client Highlights
12.15.25
Wilson Sonsini Advises SpectraWAVE on Acquisition by Philips
On December 15, 2025, Royal Philips announced it has entered into an agreement to acquire Massachusetts-based SpectraWAVE, an innovator in enhanced vascular imaging of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. Wilson Sonsini Goodrich & Rosati is advising SpectraWAVE on the transaction.
Client Highlights
12.05.25
Wilson Sonsini Advises Chronosphere on $3.35 Billion Acquisition by Palo Alto Networks
On November 19, 2025, global cybersecurity leader Palo Alto Networks announced that it has entered into a definitive agreement to acquire Chronosphere, a next-generation observability platform built to scale for the AI era, for total consideration of $3.35 billion. Wilson Sonsini Goodrich & Rosati advised Chronosphere on the transaction.
The combination of Chronosphere and Palo Alto Networks’ AgentiX platform will deliver real-time, agentic remediation for the world’s leading AI-native companies and strengthen Palo Alto Networks' ability to help organizations navigate a world where modern applications and AI workloads demand a unified data and security foundation. The acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to close in Palo Alto Networks’ second half of fiscal year 2026.
The Wilson Sonsini team that advised Chronosphere on the acquisition was led by Damien Weiss, Todd Cleary, Jack Hamilton, and Rob Broderick, and also included:
The combination of Chronosphere and Palo Alto Networks’ AgentiX platform will deliver real-time, agentic remediation for the world’s leading AI-native companies and strengthen Palo Alto Networks' ability to help organizations navigate a world where modern applications and AI workloads demand a unified data and security foundation. The acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to close in Palo Alto Networks’ second half of fiscal year 2026.
The Wilson Sonsini team that advised Chronosphere on the acquisition was led by Damien Weiss, Todd Cleary, Jack Hamilton, and Rob Broderick, and also included:
Client Highlights
10.17.25
Wilson Sonsini Advises Omeros on Asset Purchase and License Agreement with Novo Nordisk
On October 15, 2025, Novo Nordisk and Omeros Corporation announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (OMS906) in clinical development for rare blood and kidney disorders. Wilson Sonsini Goodrich & Rosati advised Omeros on the transaction.
Client Highlights
7.14.25
Wilson Sonsini Advises Windsurf on Acquisition by Cognition AI
On July 14, 2025, Cognition announced that it has signed a definitive agreement to acquire Windsurf, the agentic IDE. The acquisition includes Windsurf's IP, product, trademark, and brings the full Windsurf team to Cognition. Wilson Sonsini advised Windsurf on the transaction.
Client Highlights
5.09.25
Wilson Sonsini Advises AppLovin on Agreement to Sell Mobile Gaming Business to Tripledot
AppLovin Corporation, a leading marketing platform, announced the entry into a definitive agreement to sell its mobile gaming business to Tripledot for $400.0 million in cash consideration and equity consideration representing approximately 20% of Tripledot. The deal is anticipated to close in the second quarter of 2025, pending regulatory approvals. Wilson Sonsini Goodrich & Rosati advised AppLovin on the transaction.
Client Highlights
12.20.24
Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio
On December 19, 2024, Aadi Bioscience announced that it had entered into an agreement to sell its commercial drug product FYARRO® to KAKEN Pharmaceutical for $100 million, an agreement to sell and issue $100 million of equity in a PIPE financing, and an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics, a global Contract Research, Development and Manufacturing Organization, and Hangzhou DAC, a global leader in ADC innovation.
Client Highlights
8.23.24
Wilson Sonsini Advises Borealis Biosciences on $150 Million Series A and Strategic Collaboration Funding
On August 22, 2024, Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis AG, as well as committed strategic research collaboration funding from Novartis. Wilson Sonsini Goodrich & Rosati advised Borealis on the transaction.